Cholangiocarcinoma: Challenges and Improving the Outcomes

Suhang Verma; Jayanta Samanta; Anupam K. Singh; Rakesh Kochhar

doi:10.1055/s-0040-1709910

Journal of Digestive Endoscopy, Table of Contents

CC BY-NC-ND 4.0 · Journal of Digestive Endoscopy 2019; 10(04): 210-212
DOI: 10.1055/s-0040-1709910

Editorial

Cholangiocarcinoma: Challenges and Improving the Outcomes

Suhang Verma

¹Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

,

Jayanta Samanta

¹Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

,

Anupam K. Singh

¹Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

,

Rakesh Kochhar

¹Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

› Author Affiliations

Abstract

Full Text

References

References
1 Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 2018; 15 (02) 95-111
2 DeOliveira ML, Cunningham SC, Cameron JL. et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007; 245 (05) 755-762
3 Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: epidemiology and risk factors. Liver Int 2019; 39 (Suppl. 01) 19-31
4 Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet 2014; 383 (9935) 2168-2179
5 Olnes MJ, Erlich R. A review and update on cholangiocarcinoma. Oncology 2004; 66 (03) 167-179
6 Khan SA, Davidson BR, Goldin R. et al. British Society of Gastroenterology. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 2002; 51 (Suppl. 06) VI1-VI9
7 Goenka MK, Goenka U. Palliation: hilar cholangiocarcinoma. World J Hepatol 2014; 6 (08) 559-569
8 Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999; 230 (05) 663-671
9 Darwish Murad S, Kim WR, Harnois DM. et al. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology 2012; 143 (01) 88-98
10 Edeline J, Benabdelghani M, Bertaut A. et al. Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study. J Clin Oncol 2019; 37 (08) 658-667
11 Park J, Kim MH, Kim KP. et al. Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or radiotherapy: a large-scale observational study. Gut Liver 2009; 3 (04) 298-305
12 Valle J, Wasan H, Palmer DH. et al. ABC-02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010; 362 (14) 1273-1281
13 Patel T. Cholangiocarcinoma—controversies and challenges. Nat Rev Gastroenterol Hepatol 2011; 8 (04) 189-200
14 Madhusudhan KS, Gamanagatti S, Gupta AK. Imaging and interventions in hilar cholangiocarcinoma: a review. World J Radiol 2015; 7 (02) 28-44
15 Sangchan A, Kongkasame W, Pugkhem A, Jenwitheesuk K, Mairiang P. Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial. Gastrointest Endosc 2012; 76 (01) 93-99
16 Vienne A, Hobeika E, Gouya H. et al. Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest Endosc 2010; 72 (04) 728-735
17 Kahaleh M, Mishra R, Shami VM. et al. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. Clin Gastroenterol Hepatol 2008; 6 (03) 290-297
18 Yang J, Wang J, Zhou H. et al. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial. Endoscopy 2018; 50 (08) 751-760
19 Sudhakar A, Sravan Kumar K, Girinadh LRS, Murali Krishna P. Natural history of patients with unresectable cholangiocarcinoma. J Digest Endosc 2019; 10: 206-209